CD2AP regulates SUMOylation of CIN85 in podocytes

Molecular and Cellular Biology

Volumn 32, Issue 6, 2012, Pages 1068-1079

  Tossidou, Irini ^a   Nnthal, Rainer ^a   Klaus, Malte ^a   Teng, Beina ^a   Worthmann, Kirstin ^a   King, Benjamin L ^b   Peterson, Kevin J ^c   Haller, Hermann ^a,b   Schiffer, Mario ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b MOUNT DESERT ISLAND BIOLOGICAL LABORATORY   (United States)

^c Dartmouth College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ASSOCIATED PROTEIN; CIN85 PROTEIN; NEPHRIN; PROTEIN; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO 3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOCYTOSIS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHYLOGENY; PODOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROCESSING; SUMOYLATION; UBIQUITINATION; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL LINE; CYTOSKELETAL PROTEINS; GENE DELETION; GENE EXPRESSION REGULATION; HUMANS; MICE; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; PHYLOGENY; PODOCYTES; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMOYLATION;

MUS;

EID: 84857870665     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.06106-11     Document Type: Article

References (57)

1. Borinstein SC, et al. 2000. SETA is a multifunctional adapter protein with three SH3 domains that binds Grb2, Cbl, and the novel SB1 proteins. Cell Signal. 12:769-779.
2. Bruck S, et al. 2006. Identification of a novel inhibitory actin-capping protein binding motif in CD2-associated protein. J. Biol. Chem. 281:19196-19203.
3. Buchman VL, Luke C, Borthwick EB, Gout I, Ninkina N. 2002. Organization of the mouse Ruk locus and expression of isoforms in mouse tissues. Gene 295:13-17.
4. Carter S, Bischof O, Dejean A, Vousden KH. 2007. C-terminal modifications regulate MDM2 dissociation and nuclear export of p53. Nat. Cell Biol. 9:428-435.
5. Collec E, et al. 2007. Ubc9 interacts with Lu/BCAM adhesion glycoproteins and regulates their stability at the membrane of polarized MDCK cells. Biochem. J. 402:311-319.
6. Dehal P, Boore JL. 2005. Two rounds of whole genome duplication in the ancestral vertebrate. PLoS Biol. 3:e314.
7. Dikic I. 2002. CIN85/CMS family of adaptor molecules. FEBS Lett. 529:110-115.
8. Farrow NA, et al. 1994. Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. Biochemistry 33:5984-6003.
9. Fu C, et al. 2005. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3. Oncogene 24:5401-5413.
10. Gaidos G, Soni S, Oswald DJ, Toselli PA, Kirsch KH. 2007. Structure and function analysis of the CMS/CIN85 protein family identifies actinbundling properties and heterotypic-complex formation. J. Cell Sci. 120:2366-2377.
11. Geiss-Friedlander R, Melchior F. 2007. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 8:947-956.
12. Gout I, et al. 2000. Negative regulation of PI 3-kinase by Ruk, a novel adaptor protein. EMBO J. 19:4015-4025.
13. Grunkemeyer JA, Kwoh C, Huber TB, Shaw AS. 2005. CD2-associated protein (CD2AP) expression in podocytes rescues lethality of CD2AP deficiency. J. Biol. Chem. 280:29677-29681.
14. Haglund K, Shimokawa N, Szymkiewicz I, Dikic I. 2002. Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors. Proc. Natl. Acad. Sci. U. S. A. 99:12191-12196.
15. Havrylov S, Redowicz MJ, Buchman VL. 2010. Emerging roles of Ruk/CIN85 in vesicle-mediated transport, adhesion, migration and malignancy. Traffic 11:721-731.
16. Hernandez-Valladares M, et al. 2010. Structural characterization of a capping protein interaction motif defines a family of actin filament regulators. Nat. Struct. Mol. Biol. 17:497-503.
17. Huang TT, Wuerzberger-Davis SM, Wu ZH, Miyamoto S. 2003. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 115:565-576.
18. Huber TB, et al. 2003. Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol. Cell Biol. 23:4917-4928.
19. Johnson ES. 2004. Protein modification by SUMO. Annu. Rev. Biochem. 73:355-382.
20. Kaneko T, et al. 2005. Rho mediates endocytosis of epidermal growth factor receptor through phosphorylation of endophilin A1 by Rho-kinase. Genes Cells 10:973-987.
21. Kerscher O, Felberbaum R, Hochstrasser M. 2006. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu. Rev. Cell Dev. Biol. 22:159-180.
22. Kestila M, et al. 1998. Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol. Cell 1:575-582.
23. Kirsch KH, Georgescu MM, Ishimaru S, Hanafusa H. 1999. CMS: an adapter molecule involved in cytoskeletal rearrangements. Proc. Natl. Acad. Sci. U. S. A. 96:6211-6216.
24. Kobayashi S, Sawano A, Nojima Y, Shibuya M, Maru Y. 2004. The c-Cbl/CD2AP complex regulates VEGF-induced endocytosis and degradation of Flt-1 (VEGFR-1). FASEB J. 18:929-931.
25. Konishi H, et al. 2006. CFBP is a novel tyrosine-phosphorylated protein that might function as a regulator of CIN85/CD2AP. J. Biol. Chem. 281:28919-28931.
26. Kowanetz K, et al. 2004. CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptors. Mol. Biol. Cell 15:3155-3166.
27. Lin X, Liang M, Liang YY, Brunicardi FC, Feng XH. 2003. SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4. J. Biol. Chem. 278:31043-31048.
28. Lin X, et al. 2003. Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding. Mol. Cell 11:1389-1396.
29. Lynch DK, et al. 2003. A Cortactin-CD2-associated protein (CD2AP) complex provides a novel link between epidermal growth factor receptor endocytosis and the actin cytoskeleton. J. Biol. Chem. 278:21805-21813.
30. Martinez-Nunez MA, Perez-Rueda E, Gutierrez-Rios RM, Merino E. 2010. New insights into the regulatory networks of paralogous genes in bacteria. Microbiology 156:14-22.
31. Mayevska O, et al. 2006. Expression of adaptor protein Ruk/CIN85 isoforms in cell lines of various tissue origins and human melanoma. Exp. Oncol. 28:275-281.
32. Meulmeester E, Kunze M, Hsiao HH, Urlaub H, Melchior F. 2008. Mechanism and consequences for paralog-specific sumoylation of ubiquitin-specific protease 25. Mol. Cell 30:610-619.
33. Meulmeester E, Melchior F. 2008. Cell biology: SUMO. Nature 452:709-711.
34. Mohideen F, Lima CD. 2008. SUMO takes control of a ubiquitin-specific protease. Mol. Cell 30:539-540.
35. Muller S, Ledl A, Schmidt D. 2004. SUMO: a regulator of gene expression and genome integrity. Oncogene 23:1998-2008.
36. Pelisch F, et al. 2010. The serine/arginine-rich protein SF2/ASF regulates protein sumoylation. Proc. Natl. Acad. Sci. U. S. A. 107:16119-16124.
37. Peterson KJ, Eernisse DJ. 2001. Animal phylogeny and the ancestry of bilaterians: inferences from morphology and 18S rDNA gene sequences. Evol. Dev. 3:170-205.
38. Pichler A, Knipscheer P, Saitoh H, Sixma TK, Melchior F. 2004. The RanBP2 SUMO E3 ligase is neither. Nat. Struct. Mol. Biol. 11:984-991.
39. Pickart CM. 2001. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70:503-533.
40. Putaala H, Soininen R, Kilpelainen P, Wartiovaara J, Tryggvason K. 2001. The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. Hum. Mol. Genet. 10:1-8.
41. Sampson DA, Wang M, Matunis MJ. 2001. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J. Biol. Chem. 276:21664-21669.
42. Sato Y, et al. 2007. Regulation of the interaction of Disabled-1 with CIN85 by phosphorylation with Cyclin-dependent kinase 5. Genes Cells 12:1315-1327.
43. Schroeder B, Weller SG, Chen J, Billadeau D, McNiven MA. 2010. A Dyn2-CIN85 complex mediates degradative traffic of the EGFR by regulation of late endosomal budding. EMBO J. 29:3039-3053.
44. Shih NY, et al. 2001. CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain. Am. J. Pathol. 159:2303-2308.
45. Soubeyran P, Kowanetz K, Szymkiewicz I, Langdon WY, Dikic I. 2002. Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature 416:183-187.
46. Swanson KA, Kang RS, Stamenova SD, Hicke L, Radhakrishnan I. 2003. Solution structure of Vps27 UIM-ubiquitin complex important for endosomal sorting and receptor downregulation. EMBO J. 22:4597-4606.
47. Tatham MH, et al. 2001. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 276:35368-35374.
48. Tossidou I, et al. 2007. CD2AP/CIN85 balance determines receptor tyrosine kinase signaling response in podocytes. J. Biol. Chem. 282:7457-7464.
49. Tossidou I, et al. 2010. CIN85/RukL is a novel binding partner of nephrin and podocin and mediates slit diaphragm turnover in podocytes. J. Biol. Chem. 285:25285-25295.
50. van Duijn TJ, Anthony EC, Hensbergen PJ, Deelder AM, Hordijk PL. 2010. Rac1 recruits the adapter protein CMS/CD2AP to cell-cell contacts. J. Biol. Chem. 285:20137-20146.
51. Verdier F, et al. 2002. Ruk is ubiquitinated but not degraded by the proteasome. Eur. J. Biochem. 269:3402-3408.
52. Wakasaki T, et al. 2010. A critical role of c-Cbl-interacting protein of 85 kDa in the development and progression of head and neck squamous cell carcinomas through the ras-ERK pathway. Neoplasia 12:789-796.
53. Watanabe S, et al. 2000. Characterization of the CIN85 adaptor protein and identification of components involved in CIN85 complexes. Biochem. Biophys. Res. Commun. 278:167-174.
54. Wu H, et al. 2006. Coordinated regulation of AIB1 transcriptional activity by sumoylation and phosphorylation. J. Biol. Chem. 281:21848-21856.
55. Xue Y, Zhou F, Fu C, Xu Y, Yao X. 2006. SUMOsp: a web server for sumoylation site prediction. Nucleic Acids Res. 34:W254-W257.
56. Yang SH, Jaffray E, Hay RT, Sharrocks AD. 2003. Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity. Mol. Cell 12:63-74.
57. Yoon HY, Kales SC, Luo R, Lipkowitz S, Randazzo PA. 2011. ARAP1 association with CIN85 affects epidermal growth factor receptor endocytic trafficking. Biol. Cell 103:171-184.